---
title: "Teradyne's net revenue for the second quarter was $652 million, exceeding analysts' expectations of "
description: "Teradyne's net revenue for the second quarter was $652 million, exceeding analysts' expectations of $650.9 million; the adjusted EPS was $0.57, higher than the expected $0.54. The revenue for the thir"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/250661259.md"
published_at: "2025-07-29T21:08:59.000Z"
---

# Teradyne's net revenue for the second quarter was $652 million, exceeding analysts' expectations of 

> Teradyne's net revenue for the second quarter was $652 million, exceeding analysts' expectations of $650.9 million; the adjusted EPS was $0.57, higher than the expected $0.54. The revenue for the third quarter is expected to be between $710 million and $770 million, with analysts expecting $757.5 million, and the adjusted EPS is expected to be between $0.69 and $0.87, while analysts expect $0.89. Teradyne's U.S. stock fell over 0.3% in after-hours trading

Teradyne's net revenue for the second quarter was $652 million, while analysts expected $650.9 million.  
The adjusted EPS for the second quarter was $0.57, with analysts expecting $0.54.  
For the third quarter, revenue is expected to be between $710 million and $770 million, while analysts expect $757.5 million.  
The adjusted EPS for the third quarter is expected to be between $0.69 and $0.87, with analysts expecting $0.89.  
Teradyne (TER) fell over 0.3% in after-hours trading

### Related Stocks

- [TER.US - Teradyne](https://longbridge.com/en/quote/TER.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Check Out What Whales Are Doing With TER | Investors are showing a bullish sentiment towards Teradyne (NASDAQ:TER), with 9 unusual options trades detected, indicat | [Link](https://longbridge.com/en/news/276139761.md) |
| EU says cereulide exposure risk low after baby formula recalls | The European food and disease authorities have stated that the risk of infants being exposed to cereulide toxin in baby  | [Link](https://longbridge.com/en/news/276337078.md) |
| Did Ericsson Tie-Up to Power Wallets in Emerging Markets Just Shift Mastercard's (MA) Investment Narrative? | On February 18, 2026, Ericsson and Mastercard announced a partnership to integrate the Ericsson Fintech Platform with Ma | [Link](https://longbridge.com/en/news/276404758.md) |
| 'Skeptics Are Wrong': Top Investor Says Nvidia Stock Looks Stronger With Meta's AI Push | Nvidia (NASDAQ:NVDA) shares have faced scrutiny this year amid concerns over AI infrastructure spending and its impact o | [Link](https://longbridge.com/en/news/276397424.md) |
| Can NVIDIA Maintain its Dominancy Amidst Rising ASIC Competition | NVIDIA faces challenges in China due to regulatory actions affecting its data-center market. Concerns about long-term ma | [Link](https://longbridge.com/en/news/276370197.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.